February 24, 2022 | Join us for a look at ARUP’s accomplishments in scientific innovation and meet our committed scientists, laboratory professionals, and healthcare advisory consultants who make ARUP an industry leader. |
|
The American Initiative in Mast Cell Diseases (AIM) will hold its Physician and Investigator Conference in a hybrid format with in-person and virtual participation options at ARUP Laboratories in May 2022. |
February 16, 2022 |
ARUP President Tracy George, MD, Breaks New Ground With Nonprofit Mast Cell Disease Organization ARUP President and Chief Medical Officer Tracy George, MD, wants to establish a multidisciplinary, multinational network of centers focused on mast cell diagnosis, therapy, and education. |
ARUP’s great culture is getting noticed. Thanks to our dedicated employees for putting us on the Forbes magazine list of America’s Best Midsize Employers for 2022. |
February 11, 2022 |
ARUP Laboratories Is Ranked Among America’s Best Midsize Employers by Forbes ARUP’s commitment to creating a satisfying work environment for employees has earned it a spot on Forbes’ list of America’s Best Midsize Employers for 2022. |
February 10, 2022 |
ARUP Researchers’ Prolific Publications, Presentations Helped Advance Lab Medicine in 2021 Researchers at ARUP Laboratories made significant contributions to the advancement of laboratory medicine in 2021 as coauthors of more than 150 peer-reviewed articles. |
|
February 8, 2022 |
ARUP Earns Gold-Level Viddy Awards for Projects on COVID-19 Vaccines and Leadership Videos and podcasts produced by ARUP Laboratories about the function of COVID-19 vaccines and the challenges in navigating the pandemic have earned top prizes from the 26th annual Viddy Awards. |
|
ARUP Consult, a free source of laboratory testing information for clinicians, released several new and updated resources in January. |
February 3, 2022 |
ARUP Consult Provides New, Updated Resources on Prenatal Screening, Soft Tissue Sarcomas, COVID-19 ARUP Consult® has released new and updated resources on Prenatal Testing for Chromosomal Abnormalities and Neural Tube Defects, Soft Tissue Sarcomas, and COVID. |